GenFleet Therapeutics Announces FDA's Clinical Trial Approval for GFH925 (KRAS G12C Inhibitor) Monotherapy in Phase III Registrational Study Treating Metastatic Colorectal Cancer
/PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food...
Source: prnewswire.com
![Reggio Calabria, aumentano le corse dei treni per agevolare lo spostamento fra Regioni: 48 le frecce in più dal 17 al 21 dicembre [INFO e DETTAGLI] - Vimarsana News](https://www.strettoweb.com/wp-content/uploads/2020/10/frecciargento-treno-in-corsa.jpg)